4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-24-013629
CHIEF EXECUTIVE OFFICER sold 10,000 shares at an average $21.58 ($215,755)
- CHIEF EXECUTIVE OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $2.14 | $21,400 | 10,000 | D |
| 2024-05-16 | Sale : show line 2 in the form 10b5-1 | −8,707 | $21.52 | $187,410 | 1,293 | D |
| 2024-05-16 | Sale : show line 3 in the form 10b5-1 | −1,293 | $21.92 | $28,345 | 0 | D |
| Open-market sales · 10,000 sh · avg $21.58 · $215,755 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-16 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −10,000 | 343,381 | D |
Loading xslF345X05/form4-05172024_070501.xml…